SKF96365, originally identified as a blocker of receptor-mediated calcium entry, is widely used diagnostically, as a blocker of transient receptor potential canonical type (TRPC) channels.
信号通路
Others
靶点
TRPC
-
-
-
-
IC50
-
-
-
-
-
体外研究
SKF-96365 exhibits protective activity against MPP+ injury in PC12 cells and significantly inhibits apoptotic cell death in PC12 cells after MPP+ administration. SKF-96365 does not exert effects on necrotic cell death induced by MPP+ insult in PC12 cells. Because of its non-selective activity, SKF-96365 has been demonstrated to have effects on multiple other Ca2+ channels: it not only blocks high-voltage-activated (HVA) Ca2+ channels at typically utilized test concentrations, but also potently inhibits low-voltage -activated (LVA) T-type Ca2+ channels in HEK293 cells. The exact effect of SKF-96365 on intracellular calcium homeostasis might dependent on cell types and experimental models used.
体内研究
SKF-96365 treatment inhibited the calcium/calmodulin-dependent protein kinase IIγ (CaMKIIγ)/AKT signaling cascade in vitro and in vivo.
临床实验
N/A
特征
N/A
相关实验数据(此数据来自于公开文献,碧云天并不保证其有效性):
▼
▲
酶活性检测实验
方法
N/A
细胞实验
细胞系
PC12 cells
浓度
1μM, 10μM, 50μM
处理时间
30 min
方法
To investigate whether SKF-96365 could protect PC12 cells from injury induced by MPP+ insult, cultured PC12 cells are pretreated with SKF-96365 in different concentrations (1μM, 10μM or 50μM) 30 min before MPP+ addition. The cells viability is measured 24h after MPP+ insult by using the cell proliferation reagent WST-1.
动物实验
动物模型
C57BL/6N mice
配制
0.9% sterile saline
剂量
0.02μMol-0.2μMol/2μl/mouse
给药方式
intrastriatally
参考文献:
1. Singh A, et al. Br J Pharmacol. 2010, 160(6):1464-1475.
2. Chen T, et al. PLoS One. 2013, 8(1):e55601.
3. Yao H, et al. Cell Death Differ. 2009, 16(12):1681-1693.
4. Jing Z, et al. Cancer Lett. 2016, 372(2):226-38.